标题/作者	年份
Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein AC Walls, YJ Park, MA Tortorici, A Wall, AT McGuire, D Veesler Cell 181 (2), 281-292. e6	2020
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 Y Huang, C Yang, X Xu, W Xu, S Liu Acta Pharmacologica Sinica 41 (9), 1141-1149	2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ... Nature 583 (7815), 290-295	2020
SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2 TM Clausen, DR Sandoval, CB Spliid, J Pihl, HR Perrett, CD Painter, ... Cell 183 (4), 1043-1057. e15	2020
Structural insights into coronavirus entry MA Tortorici, D Veesler Advances in virus research 105, 93-116	2019
COVID-19: Immunology and treatment options S Felsenstein, JA Herbert, PS McNamara, CM Hedrich Clinical immunology 215, 108448	2020
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies CO Barnes, AP West, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ... Cell 182 (4), 828-842. e16	2020
Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein L Casalino, Z Gaieb, JA Goldsmith, CK Hjorth, AC Dommer, AM Harbison, ... ACS central science 6 (10), 1722-1734	2020
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion DJ Benton, AG Wrobel, P Xu, C Roustan, SR Martin, PB Rosenthal, ... Nature 588 (7837), 327-330	2020
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection J Fantini, C Di Scala, H Chahinian, N Yahi International journal of antimicrobial agents 55 (5), 105960	2020
Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence C Sardu, J Gambardella, MB Morelli, X Wang, R Marfella, G Santulli Journal of clinical medicine 9 (5), 1417	2020
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor J Yang, SJL Petitjean, M Koehler, Q Zhang, AC Dumitru, W Chen, ... Nature communications 11 (1), 4541	2020
Deducing the N-and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 A Shajahan, NT Supekar, AS Gleinich, P Azadi Glycobiology 30 (12), 981-988	2020
Subunit vaccines against emerging pathogenic human coronaviruses N Wang, J Shang, S Jiang, L Du Frontiers in microbiology 11, 298	2020
A review of current interventions for COVID-19 prevention D Pradhan, P Biswasroy, PK Naik, G Ghosh, G Rath Archives of medical research 51 (5), 363-374	2020
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? A Huertas, D Montani, L Savale, J Pichon, L Tu, F Parent, C Guignabert, ... European Respiratory Journal 56 (1)	2020
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation SX Gu, T Tyagi, K Jain, VW Gu, SH Lee, JM Hwa, JM Kwan, DS Krause, ... Nature Reviews Cardiology 18 (3), 194-209	2021
Controlling the SARS-CoV-2 spike glycoprotein conformation R Henderson, RJ Edwards, K Mansouri, K Janowska, V Stalls, ... Nature structural & molecular biology 27 (10), 925-933	2020
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein C Toelzer, K Gupta, SKN Yadav, U Borucu, AD Davidson, ... Science 370 (6517), 725-730	2020
The variant gambit: COVID-19’s next move JA Plante, BM Mitchell, KS Plante, K Debbink, SC Weaver, VD Menachery Cell host & microbe 29 (4), 508-515	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。